Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
2012
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
General Prediction of Peptide-MHC Binding Modes Using Incremental Docking: A Proof of Concept
2018
Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Elevated Pre–Antiretroviral Therapy CD39+CD8+ T Cell Frequency Is Associated With Early Mortality in Advanced Human Immunodeficiency Virus/Tuberculosis Co-infection
2017 StandoutNobel
Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir
2011
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response
2009
T cell exhaustion
2011 Standout
Immune Responses to Hepatitis C Virus (HCV) Infection and the Prospects for an Effective HCV Vaccine or Immunotherapies
2013
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Interferon α–Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1
2012 StandoutNobel
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
2010
Deep sequencing: Becoming a critical tool in clinical virology
2014
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
2015
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
2010
Hepatitis C virus–specific CD4+ T cell phenotype and function in different infection outcomes
2020
Immune Responses to HCV and Other Hepatitis Viruses
2014
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
2009
Adaptive Immunity to the Hepatitis C Virus
2010
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model
2015
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1
2017
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma
2012
Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
2009
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection
2011
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
2020
Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization
2008
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
2010
DnaSP 6: DNA Sequence Polymorphism Analysis of Large Data Sets
2017 Standout
Elucidation of Hepatitis C Virus Transmission and Early Diversification by Single Genome Sequencing
2012
T cell responses in hepatitis C: the good, the bad and the unconventional
2011
Molecular and cellular insights into T cell exhaustion
2015 Standout
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion
2012
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection
2010
Immunomodulation in Cystic Fibrosis: Why and How?
2020
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Origin of hepatitis C virus genotype 3 in Africa as estimated through an evolutionary analysis of the full-length genomes of nine subtypes, including the newly sequenced 3d and 3e
2014
Tracking the Evolution of MultipleIn VitroHepatitis C Virus Replicon Variants under Protease Inhibitor Selection Pressure by 454 Deep Sequencing
2010
Will There Be a Vaccine to Prevent HCV Infection?
2014
Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t
2009
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection
2016
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8 + Memory T Cells
2008
Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing
2010
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
2012 Science
Recombination in Hepatitis C Virus
2011
Regulation of Trypanosoma cruzi-Induced Myocarditis by Programmed Death Cell Receptor 1
2011 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection
2008
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies
2016
The Frequency of CD127 + Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection
2013 StandoutNobel
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Immune control and failure in HCV infection—tipping the balance
2014
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
A spatial view of the CD8+ T‐cell response: the case of HCV
2011
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Emerging concepts in immunity to hepatitis C virus infection
2013
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
De novo design of protein logic gates
2020 StandoutScienceNobel
Works of Andrew Berical being referenced
Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
2010
Whole Genome Pyrosequencing of Rare Hepatitis C Virus Genotypes Enhances Subtype Classification and Identification of Naturally Occurring Drug Resistance Variants
2012
Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
2019
High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8 + and CD4 + T Cells during Acute HCV Infection, Irrespective of Clinical Outcome
2007
Temporal Dynamics of a Predominant Protease Inhibitor–Resistance Mutation in a Treatment-Naive, Hepatitis C Virus–Infected Individual
2009
A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame
2008
Viral Sequence Evolution in Acute Hepatitis C Virus Infection
2007
Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution
2009
Compensatory Mutations Restore the Replication Defects Caused by Cytotoxic T Lymphocyte Escape Mutations in Hepatitis C Virus Polymerase
2011
Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non–genotype 1 infection
2007